NCT03219463

Brief Summary

The purpose of our graduate student research study is to observe the effects of ginger on hsCRP, IL-6, and TNF-α levels in exercising individuals based on their level of activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 17, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

August 21, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

June 25, 2018

Status Verified

June 1, 2018

Enrollment Period

9 months

First QC Date

June 27, 2017

Last Update Submit

June 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • SF-36 Questionnaire

    Quality of life will be assessed using the 36-item Short Form Survey Instrument (SF-36). It was developed by the RAND corporation. The SF-36 is a well accepted and valid survey used to assess overall health measuring 8 different dimensions including physical and social functionality and limitations, mental health, vitality, pain, general health perception, and health change.20 It is a self-administered survey that takes about 10 minutes to complete.

    Change from baseline to end of 8 weeks.

Secondary Outcomes (1)

  • Inflammatory Bio Markers

    A composite measurement from :1) at baseline 2) mid point (at 4weeks) and at 3) end of 8 weeks.

Study Arms (2)

Regular Exercise Group

EXPERIMENTAL

at least 30 minutes of moderate to vigorous activity at least 3 times per week. Will recieve 3 grams of ginger for 8 weeks.

Dietary Supplement: Ginger

Non Regular Exercise Group

ACTIVE COMPARATOR

at least 30 minutes of moderate to vigorous activity 1-2 times per week. Will recieve 3 grams of ginger for 8 weeks.

Dietary Supplement: Ginger

Interventions

GingerDIETARY_SUPPLEMENT

3g ginger powder supplement once a day with meals (preferably in the morning) for a duration of 8 weeks. Powder can be mixed with juice or water.

Non Regular Exercise GroupRegular Exercise Group

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • Various levels of activity outlined by the General Physical Activities Defined by Level of Intensity by the American College of Sports Medicine (ACSM) and the Centers for Disease Control and Prevention (CDC).
  • Regular Exercisers- at least 30 minutes of moderate to vigorous activity at least 3 times per week.
  • Non-regular Exercisers- at least 30 minutes of moderate to vigorous activity 1-2 times per week.

You may not qualify if:

  • Individuals currently taking...
  • Vit D
  • Aspirin
  • Coumadin
  • Ginger supplements more than 1x/week within the last month
  • Heparin
  • NSAIDs
  • Pain meds
  • Individuals with chronic inflammatory conditions such as Cancer, CVD, Diabetes, Gastroesophageal reflux disease (GERD), Ginger allergies, Metabolic Syndrome, and/or autoimmune diseases such as Rheumatoid Arthritis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loma Linda Health

Loma Linda, California, 92350, United States

Location

MeSH Terms

Interventions

ginger extract

Study Officials

  • JeJe Noval, PhD

    Loma Linda University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 27, 2017

First Posted

July 17, 2017

Study Start

August 21, 2017

Primary Completion

June 1, 2018

Study Completion

June 1, 2018

Last Updated

June 25, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations